Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke

BACKGROUND: Sovateltide (IRL-1620, PMZ-1620), an endothelin-B receptor agonist, has been previously shown to increase cerebral blood flow, have anti-apoptotic activity and produce neurovascular remodeling when administered intravenously following acute cerebral ischemic stroke in rats. Its safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulati, Anil, Agrawal, Nilesh, Vibha, Deepti, Misra, U. K., Paul, Birinder, Jain, Dinesh, Pandian, Jeyaraj, Borgohain, Rupam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872992/
https://www.ncbi.nlm.nih.gov/pubmed/33428177
http://dx.doi.org/10.1007/s40263-020-00783-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872992/
https://www.ncbi.nlm.nih.gov/pubmed/33428177
http://dx.doi.org/10.1007/s40263-020-00783-9

Ejemplares similares